CARDERO RESOURCE
Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases in Switzerland, Iceland, and internationally. The company's lead product candidate is OCS-01, a topical dexamethasone optireach formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b cli… Read more
CARDERO RESOURCE (CR5) - Total Assets
Latest total assets as of September 2025: €167.84 Million EUR
Based on the latest financial reports, CARDERO RESOURCE (CR5) holds total assets worth €167.84 Million EUR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
CARDERO RESOURCE - Total Assets Trend (2020–2024)
This chart illustrates how CARDERO RESOURCE’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
CARDERO RESOURCE - Asset Composition Analysis
Current Asset Composition (December 2024)
CARDERO RESOURCE's total assets of €167.84 Million consist of 87.2% current assets and 12.8% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 23.0% |
| Accounts Receivable | €0.00 | 0.0% |
| Inventory | €0.00 | 0.0% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €13.29 Million | 11.0% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2020–2024)
This chart illustrates how CARDERO RESOURCE's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: CARDERO RESOURCE's current assets represent 87.2% of total assets in 2024, an increase from 37.6% in 2020.
- Cash Position: Cash and equivalents constituted 23.0% of total assets in 2024, down from 30.2% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, an increase from 0.0% in 2020.
- Asset Diversification: The largest asset category is intangible assets at 11.0% of total assets.
CARDERO RESOURCE Competitors by Total Assets
Key competitors of CARDERO RESOURCE based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
CARDERO RESOURCE - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - CARDERO RESOURCE generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - CARDERO RESOURCE is currently not profitable relative to its asset base.
CARDERO RESOURCE - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.47 | 4.02 | 1.97 |
| Quick Ratio | 4.47 | 4.02 | 1.97 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €117.18 Million | € 83.77 Million | € 11.64 Million |
CARDERO RESOURCE - Advanced Valuation Insights
This section examines the relationship between CARDERO RESOURCE's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.74 |
| Latest Market Cap to Assets Ratio | 7.83 |
| Asset Growth Rate (YoY) | 5.2% |
| Total Assets | €120.35 Million |
| Market Capitalization | $942.95 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values CARDERO RESOURCE's assets at a significant premium ( 7.83x), suggesting investors see substantial growth potential or unique competitive advantages.
Positive Asset Growth: CARDERO RESOURCE's assets grew by 5.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for CARDERO RESOURCE (2020–2024)
The table below shows the annual total assets of CARDERO RESOURCE from 2020 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €120.35 Million | +5.25% |
| 2023-12-31 | €114.35 Million | +208.56% |
| 2022-12-31 | €37.06 Million | -36.15% |
| 2021-12-31 | €58.04 Million | +254.29% |
| 2020-12-31 | €16.38 Million | -- |